IPO registrations (S-1, F-1) · Registrants
Propanc Biopharma, Inc.
- SEC CIK
- 1517681 · filings on EDGAR ↗
- Former names
- Propanc Health Group Corp (2011–2017)
- Registration
- Form S-1, first filed 2011-06-23, last 2026-10-05; 17 initial registrations, 24 amendments
- Outcome
- Final prospectus filed 2023-10-17; declared effective 2011-12-15; withdrawal requested 2016-12-12
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 302/6 BUTLER STREET, Camberwell, Victoria, C3 3124
- EIN
- 33-0662986
- Ticker
- PPCB (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Propanc Biopharma, Inc. on the corporate pages
Offering terms
- Final price
- $0.01 per share (424B4 filed 2023-10-17)
- Listing
- OTC under the symbol PPCB
- Lead underwriters
- of Contents
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: Propanc Biopharma, Inc. EXACT (CIK (EXACT))
- SEC filer: Propanc Biopharma, Inc. EXACT (CIK (EXACT))
Filings 67
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2011-06-23 | S-1 | S-1 (registration) | Propanc Health Group Corp | 0001354488-11-001953 ↗ |
| 2011-08-18 | S-1/A | S-1/A (amendment) | Propanc Health Group Corp | 0001354488-11-002979 ↗ |
| 2011-09-30 | S-1/A | S-1/A (amendment) | Propanc Health Group Corp | 0001354488-11-003637 ↗ |
| 2011-10-27 | S-1/A | S-1/A (amendment) | Propanc Health Group Corp | 0001354488-11-003958 ↗ |
| 2011-11-14 | S-1/A | S-1/A (amendment) | Propanc Health Group Corp | 0001354488-11-004277 ↗ |
| 2011-12-08 | S-1/A | S-1/A (amendment) | Propanc Health Group Corp | 0001354488-11-004896 ↗ |
| 2011-12-15 | EFFECT | EFFECT (declared effective) | Propanc Health Group Corp | 9999999995-11-003546 ↗ |
| 2012-04-13 | EFFECT | EFFECT (declared effective) | Propanc Health Group Corp | 9999999995-12-001037 ↗ |
| 2013-01-10 | EFFECT | EFFECT (declared effective) | Propanc Health Group Corp | 9999999995-13-000157 ↗ |
| 2015-11-23 | S-1 | S-1 (registration) | Propanc Health Group Corp | 0001144204-15-067435 ↗ |
| 2015-12-10 | S-1/A | S-1/A (amendment) | Propanc Health Group Corp | 0001144204-15-070249 ↗ |
| 2015-12-10 | EFFECT | EFFECT (declared effective) | Propanc Health Group Corp | 9999999995-15-003242 ↗ |
| 2016-03-25 | S-1 | S-1 (registration) | Propanc Health Group Corp | 0001144204-16-090186 ↗ |
| 2016-04-14 | S-1/A | S-1/A (amendment) | Propanc Health Group Corp | 0001144204-16-094251 ↗ |
| 2016-04-18 | EFFECT | EFFECT (declared effective) | Propanc Health Group Corp | 9999999995-16-004256 ↗ |
| 2016-08-19 | S-1 | S-1 (registration) | Propanc Health Group Corp | 0001144204-16-120372 ↗ |
| 2016-10-18 | EFFECT | EFFECT (declared effective) | Propanc Health Group Corp | 9999999995-16-005996 ↗ |
| 2016-10-18 | EFFECT | EFFECT (declared effective) | Propanc Health Group Corp | 9999999995-16-005997 ↗ |
| 2016-12-12 | RW | RW (withdrawal request) | Propanc Health Group Corp | 0001144204-16-139000 ↗ |
| 2018-10-17 | S-1 | S-1 (registration) | Propanc Biopharma, Inc. | 0001493152-18-014592 ↗ |
| 2018-10-30 | EFFECT | EFFECT (declared effective) | Propanc Biopharma, Inc. | 9999999995-18-002760 ↗ |
| 2019-02-25 | S-1 | S-1 (registration) | Propanc Biopharma, Inc. | 0001493152-19-002526 ↗ |
| 2019-03-07 | EFFECT | EFFECT (declared effective) | Propanc Biopharma, Inc. | 9999999995-19-000396 ↗ |
| 2019-05-23 | S-1 | S-1 (registration) | Propanc Biopharma, Inc. | 0001493152-19-008117 ↗ |
| 2019-06-14 | S-1/A | S-1/A (amendment) | Propanc Biopharma, Inc. | 0001493152-19-009248 ↗ |
| 2019-06-21 | EFFECT | EFFECT (declared effective) | Propanc Biopharma, Inc. | 9999999995-19-001404 ↗ |
| 2019-08-19 | RW | RW (withdrawal request) | Propanc Biopharma, Inc. | 0001493152-19-012952 ↗ |
| 2019-08-21 | RW | RW (withdrawal request) | Propanc Biopharma, Inc. | 0001493152-19-013211 ↗ |
| 2019-12-12 | S-1 | S-1 (registration) | Propanc Biopharma, Inc. | 0001493152-19-019118 ↗ |
| 2020-01-24 | S-1/A | S-1/A (amendment) | Propanc Biopharma, Inc. | 0001493152-20-001059 ↗ |
| 2020-02-14 | EFFECT | EFFECT (declared effective) | Propanc Biopharma, Inc. | 9999999995-20-000366 ↗ |
| 2020-05-13 | S-1 | S-1 (registration) | Propanc Biopharma, Inc. | 0001493152-20-008544 ↗ |
| 2020-06-26 | S-1/A | S-1/A (amendment) | Propanc Biopharma, Inc. | 0001493152-20-011964 ↗ |
| 2020-07-17 | S-1/A | S-1/A (amendment) | Propanc Biopharma, Inc. | 0001493152-20-013482 ↗ |
| 2020-08-13 | S-1/A | S-1/A (amendment) | Propanc Biopharma, Inc. | 0001493152-20-015435 ↗ |
| 2020-10-14 | S-1/A | S-1/A (amendment) | Propanc Biopharma, Inc. | 0001493152-20-019397 ↗ |
| 2020-11-03 | S-1/A | S-1/A (amendment) | Propanc Biopharma, Inc. | 0001493152-20-020409 ↗ |
| 2020-11-12 | EFFECT | EFFECT (declared effective) | Propanc Biopharma, Inc. | 9999999995-20-003140 ↗ |
| 2022-01-14 | EFFECT | EFFECT (declared effective) | Propanc Biopharma, Inc. | 9999999995-22-000141 ↗ |
| 2022-02-03 | S-1 | S-1 (registration) | Propanc Biopharma, Inc. | 0001493152-22-003104 ↗ |
| 2022-02-10 | S-1/A | S-1/A (amendment) | Propanc Biopharma, Inc. | 0001493152-22-003713 ↗ |
| 2022-02-11 | EFFECT | EFFECT (declared effective) | Propanc Biopharma, Inc. | 9999999995-22-000433 ↗ |
| 2023-03-27 | EFFECT | EFFECT (declared effective) | Propanc Biopharma, Inc. | 9999999995-23-000668 ↗ |
| 2023-08-11 | S-1 | S-1 (registration) | Propanc Biopharma, Inc. | 0001493152-23-027886 ↗ |
| 2023-10-06 | S-1/A | S-1/A (amendment) | Propanc Biopharma, Inc. | 0001493152-23-036563 ↗ |
| 2023-10-10 | S-1/A | S-1/A (amendment) | Propanc Biopharma, Inc. | 0001493152-23-036599 ↗ |
| 2023-10-12 | EFFECT | EFFECT (declared effective) | Propanc Biopharma, Inc. | 9999999995-23-002978 ↗ |
| 2023-10-17 | 424B4 | 424B4 (final prospectus) | Propanc Biopharma, Inc. | 0001493152-23-037420 ↗ |
| 2024-10-30 | S-1 | S-1 (registration) | Propanc Biopharma, Inc. | 0001493152-24-042965 ↗ |
| 2025-03-31 | S-1/A | S-1/A (amendment) | Propanc Biopharma, Inc. | 0001641172-25-001355 ↗ |
| 2025-04-02 | S-1/A | S-1/A (amendment) | Propanc Biopharma, Inc. | 0001641172-25-002435 ↗ |
| 2025-04-08 | S-1/A | S-1/A (amendment) | Propanc Biopharma, Inc. | 0001641172-25-003278 ↗ |
| 2025-04-25 | S-1/A | S-1/A (amendment) | Propanc Biopharma, Inc. | 0001641172-25-006154 ↗ |
| 2025-05-30 | S-1/A | S-1/A (amendment) | Propanc Biopharma, Inc. | 0001641172-25-013004 ↗ |
| 2025-07-28 | S-1/A | S-1/A (amendment) | Propanc Biopharma, Inc. | 0001641172-25-021182 ↗ |
| 2025-08-13 | EFFECT | EFFECT (declared effective) | Propanc Biopharma, Inc. | 9999999995-25-002596 ↗ |
| 2025-08-18 | 424B4 | 424B4 (final prospectus) | Propanc Biopharma, Inc. | 0001641172-25-024613 ↗ |
| 2025-12-30 | S-1 | S-1 (registration) | Propanc Biopharma, Inc. | 0001493152-25-029472 ↗ |
| 2026-01-09 | EFFECT | EFFECT (declared effective) | Propanc Biopharma, Inc. | 9999999995-26-000139 ↗ |
| 2026-02-02 | S-1 | S-1 (registration) | Propanc Biopharma, Inc. | 0001493152-26-004792 ↗ |
| 2026-02-19 | S-1/A | S-1/A (amendment) | Propanc Biopharma, Inc. | 0001493152-26-007492 ↗ |
| 2026-02-24 | EFFECT | EFFECT (declared effective) | Propanc Biopharma, Inc. | 9999999995-26-000658 ↗ |
| 2026-04-10 | S-1 | S-1 (registration) | Propanc Biopharma, Inc. | 0001493152-26-016228 ↗ |
| 2026-04-20 | EFFECT | EFFECT (declared effective) | Propanc Biopharma, Inc. | 9999999995-26-001258 ↗ |
| 2026-07-17 | S-1 | S-1 (registration) | Propanc Biopharma, Inc. | 0001493152-26-033807 ↗ |
| 2026-07-27 | EFFECT | EFFECT (declared effective) | Propanc Biopharma, Inc. | 9999999995-26-002465 ↗ |
| 2026-10-05 | S-1 | S-1 (registration) | Propanc Biopharma, Inc. | 0001493152-26-045770 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-10 | S-1/A | registration statement | $0.01 | - | - | OTC PPCB | 1 | primary document; price line, cover names 1 | document ↗ | |
| 2023-10-17 | 424B4 | final prospectus | $0.01 | - | - | OTC PPCB | 1 | primary document; price line, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Nathanielsz James Andrew | Director,Officer; Director,Officer,TenPercentOwner | CEO, Acting CFO, Chairman; CEO/CFO; CEO, CFO, Secretary, Treasurer; Chief Executive Officer | 6 | 2012–2021 | |
| Kenyon Julian Norman | Director; Director,Officer; Director,TenPercentOwner | Chief Scientific Officer | 5 | 2012–2021 | |
| Campiciano Carlo M | Officer | CFO & Secretary | 1 | 2019 | |
| ZELINGER JOSEF | Director | 2 | 2021–2023 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2023-11-03 | Propanc Biopharma, Inc. | Pharmaceuticals | $40,000 | $40,000 | 1 | 1 |
| 2023-10-26 | Propanc Biopharma, Inc. | Pharmaceuticals | $61,000 | $61,000 | 1 | 1 |
| 2023-08-31 | Propanc Biopharma, Inc. | Pharmaceuticals | $55,000 | $55,000 | 1 | 1 |
| 2023-08-31 | Propanc Biopharma, Inc. | Pharmaceuticals | $72,500 | $72,500 | 1 | 1 |
| 2023-08-30 | Propanc Biopharma, Inc. | Pharmaceuticals | $120,000 | $120,000 | 1 | 1 |
| 2023-08-16 | Propanc Biopharma, Inc. | Pharmaceuticals | $65,000 | $65,000 | 1 | 1 |
| 2023-08-15 | Propanc Biopharma, Inc. | Pharmaceuticals | $45,000 | $45,000 | 1 | 1 |
| 2020-04-17 | Propanc Biopharma, Inc. | Pharmaceuticals | $450,000 | $450,000 | 1 | 1 |
| 2019-01-02 | Propanc Biopharma, Inc. | Biotechnology | $126,000 | $126,000 | 1 | 1 |
| 2019-01-02 | Propanc Biopharma, Inc. | Biotechnology | $105,000 | $105,000 | 1 | 1 |
| 2018-10-11 | Propanc Biopharma, Inc. | Biotechnology | $422,000 | $422,000 | 2 | 1 |
| 2018-10-01 | Propanc Biopharma, Inc. | Biotechnology | $6,315,435 | $6,315,435 | 8 | 1 |
| 2018-09-17 | Propanc Biopharma, Inc. | Biotechnology | $158,000 | $158,000 | 2 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | Propanc Biopharma, Inc. | Form D private offerings | CIK (EXACT) | |
| SEC filer | Propanc Biopharma, Inc. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, C3 first:
- Pharmaxis Ltd. C3
- Benitec Biopharma LTD/ADR C3
- Parnell Pharmaceuticals Holdings Ltd C3
- Immuron Ltd C3
- Beroni Group Ltd C3
- Medlab Clinical Ltd. C3
- Telix Pharmaceuticals Ltd C3
- MorphoSys AG 2M
- Affimed N.V. 2M
- InflaRx N.V. 2M
In other datasets, the same topic (Health) in C3:
- Form D issuer: Botanix Pharmaceuticals Ltd. (Form D private offerings)
Interests: Pharmaceutical Preparations · Health